drugset / Trial / NCT00483717
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
RandomizedParallel-groupDouble-blindTreatment
Summary
The study evaluates the efficacy and safety of using ketorolac as a nasal spray for the acute treatment of migraine.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac Tromethamine | Small molecule | 31.5 mg | Intranasal |
| Background | Lidocaine | Other / unclassified | 6 % | Intranasal |